For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250422:nRSV6885Fa&default-theme=true
RNS Number : 6885F Eurocell plc 22 April 2025
22 April 2025
EUROCELL PLC
(the "Company")
Director/PDMR Shareholding
Eurocell plc (the "Company") announces that, on 17 April 2025:
· options granted on 13 April 2022 under the Eurocell plc Deferred
Share Plan 2015, to acquire ordinary shares in the Company, were exercised by
a director; and
· shares acquired, as a result of the above exercise, were sold by the
above director to cover the associated tax and national insurance liabilities.
The notifications set out below, made in accordance with the requirements of
the EU Market Abuse Regulation, provides further details.
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them.
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Michael Scott
2. Reason for the notification
a) Position / status Chief Financial Officer
b) Initial notification / amendment Initial Notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Eurocell plc
b) Legal Entity Identifier 213800RH62IQ7S9OFQ55
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Ordinary shares of £0.001 each in the Company ("Ordinary Shares")
ISIN Number GB00BVV2KN49
b) Nature of the transaction Exercise of nil-cost options to acquire ordinary shares under the Eurocell plc
Deferred Share Plan 2015
c) Price(s) and volume(s) Price(s) Volume(s)
£nil (option price) 34,079
d) Aggregated information
- Aggregated volume
- Aggregated price N/A - single transactions
- Aggregated total
e) Date of the transaction 17 April 2025
f) Place of the transaction Outside a trading venue
d)
Aggregated information
- Aggregated volume
- Aggregated price
- Aggregated total
N/A - single transactions
e)
Date of the transaction
17 April 2025
f)
Place of the transaction
Outside a trading venue
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Michael Scott
2. Reason for the notification
a) Position / status Chief Financial Officer
b) Initial notification / amendment Initial Notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Eurocell plc
b) Legal Entity Identifier 213800RH62IQ7S9OFQ55
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Ordinary shares of £0.001 each in the Company ("Ordinary Shares")
ISIN Number GB00BVV2KN49
b) Nature of the transaction Sale of ordinary shares, acquired under the Eurocell plc Deferred Share Plan
2015, to cover the associated tax and national insurance liabilities
c) Price(s) and volume(s) Price(s) Volume(s)
£1.495 16,099
d) Aggregated information
- Aggregated volume
- Aggregated price N/A - single transactions
- Aggregated total
e) Date of the transaction 17 April 2025
f) Place of the transaction London Stock Exchange, Main Market (XLON)
d)
Aggregated information
- Aggregated volume
- Aggregated price
- Aggregated total
N/A - single transactions
e)
Date of the transaction
17 April 2025
f)
Place of the transaction
London Stock Exchange, Main Market (XLON)
For further information:
Eurocell plc 01773
842 100
Vicky Williams
Group Company Secretary
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHPPUQGCUPAGUP